Media Center

In this current attendee snapshot, you will find the titles and companies of those who lead anti-counterfeiting efforts and who have signed up to be in attendance. Will you be joining them?

We are taking early registrations for this fantastic event. Simply download this form and send it back to enquiryiqpc@iqpc.com to fast track your attendance to this industry-leading event!

Present your manager with this customizable letter detailing the reasons why you should attend the upcoming event and you'll be sure to receive approval.

Detailed is an abbreviated list of Anti-Counterfeiting executives who attended the last iteration of the event. Will you be there to see what they experienced?

The proliferation of online pharmacies has made it easier than ever for counterfeit medications to reach wider audiences. Ahead of the summit, we took a look at INTERPOL's largest counterfeit seizure in 2018. This year's Pangea enforcement operation, which took place October 9-16, focused on taking down rogue online pharmacies....

Developing countries are the worst affected from counterfeit pharmaceuticals, regulatory structures are weaker and measurement and oversight is difficult. According to the World Health Organization, an estimated 1 in 10 medical products in low- and middle-income countries is substandard or falsified. This heat map specifically focuses in on the largest...

A new survey by Strategy&, PwC’s strategy consulting business, has found that pharmaceutical executives generally aren’t inclined to spend more to fight fakes, despite their awareness that current measures don’t go far enough. Not only do these executives misjudge their own vulnerability, but they also overlook the opportunities awaiting those...

This video takes a look at INTERPOL's largest counterfeit seizure in 2018. This year's Pangea enforcement operation, which took place October 9-16, focused on taking down rogue online pharmacies. Take a look at the video!For the video sent to your inbox, please email enquriyiqpc@iqpc.com

In preparation for the Pharma Anti-Counterfeiting & Brand Protection Summit, we wanted to exclusively share these past presentations with you. Below you will find expert content on:SWOT Analysis: Fracture Points within your Cyber Security: Joseph Buerger, Brand Protection Technologies Manager, Takeda PharmaceuticalsExploring Cross Agency Collaboration in Operation Pangea X: Shauna...

In this presentation, Joseph Buerger, Brand Protection Technologies Manager, Takeda Pharmaceuticals, presents on:Identifying the areas cyber supply chain risks touch such as sourcing, vendor management, supply chain continuity and quality, transportation security and moreReviewing key cyber supply chain risks that exist in the above areasExploring the roles people, processes, and...

In this presentation, Shauna Frye, Special Agent, FDA, Office of Criminal Investigations; and Edwardo Rosario, Special Agent, DHS | Homeland Security Investigations (HSI), present on:Examining the role of multiple agencies in Operation Pangea XCreating a mechanism for effective coordination between all stakeholders of the public and private sectorsHow to connect...

In this presentation, Alaina van Horn, Attorney, U.S. Customs & Border Protection, Office of International Trade, Intellectual Property Rights Enforcement, presents on:Learning what drugs are at most risk and where to pay most attentionDiscussing the global impact and economic costStrategizing Intellectual Property Protection for patents, trademarks and copyrightsLearn a legal...

In this presentation, Dan Cohen, Executive Vice President, Government & Public Relations, presents on: Why you should invest in ADFs and the investments made so farUnderstanding how ADFs are effective in reducing the diversion of pharmaceutical productsComparing recent data on drug abuse and diversion before and after formulationLearning from law...

In this presentation, Gregory Bylo, VP Healthcare, GS1 US, presents on:Why are data standards important?Identifying how these standards effect you and what to watch out forHow GS1 standards are helping to ensure you meet the DSCSA’s requirements for data exchange while protecting from counterfeitersUsing the enhanced EPCIS 1.2 to meet...

Prior to the Anti-Counterfeiting in Pharma & Brand Protection Summit in March, we sat down for an interview with Brian Files to discuss the largest challenges and implications in integrating serialization into the supply chain, what 2024 and beyond will look like, how new technologies will affect us, the major...

Estimates suggest that the global counterfeit drug market sits somewhere between US$75 and $200 billion and represents 10–50 percent of all drugs sold in some low-income countries. This article looks at the past, present, and future of counterfeit drug screening.

Secure exclusive sponsorship and exhibition opportunities through Thought Leadership Sessions, Workshops Presentations, Innovative Demo Drives and Exhibit Displays. Download the Sponsorship Prospectus to find out more...Alternatively, feel free to send your request to enquiryiqpc@iqpc.com to receive your copy via email.